Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 CAD | +1.56% | +16.77% | +364.29% |
Business Summary
Number of employees: 16
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 11-09-30 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
David Hyman
DFI | Director of Finance/CFO | - | Feb. 13 |
Delphine Davan
IRC | Investor Relations Contact | - | 23-08-13 |
Minh To
PRN | Corporate Officer/Principal | - | 23-08-13 |
Eamonn Peters
PRN | Corporate Officer/Principal | - | 23-08-13 |
Evelyn Pau
PRN | Corporate Officer/Principal | - | 23-08-13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 19-09-23 |
Albert Beraldo
BRD | Director/Board Member | - | 16-11-21 |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
Founder | - | 11-09-30 | |
Jack Geltosky
BRD | Director/Board Member | 78 | 20-09-29 |
John Sampson
BRD | Director/Board Member | - | 21-09-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 69,637,469 | 48,558,694 ( 69.73 %) | 0 | 69.73 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+364.29% | 99.12M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.02% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- MDNA Stock
- Company Medicenna Therapeutics Corp.